Shervin Assassi MD

Professor & Director, Division of Rheumatology, University of Texas Health Science Center at Houston

6431 Fannin StMsb 5.270Houston, TX 77030
Phone+1 713-500-6900
Fax+1 713-500-0580

Dr. Assassi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Assassi's full profile Already have an account?

Education & Training

University of Texas Health Science Center at HoustonFellowship, Rheumatology, 2003 - 2005
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2000 - 2003
Albert Ludwigs University Faculty of MedicineClass of 1999

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 2005 - 2027
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise E HR, Allscripts, 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014-2017
Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Comparative Effectiveness in Systemic Sclerosis-Associated Interstitial Lung Disease: Interpreting Signals Amid Heterogeneity.
Michelle A Ghebranious, Shervin Assassi
Annals of the American Thoracic Society. 2026-08-28
Macropinocytosis inhibition attenuates fibroblast activation and bleomycin-induced skin fibrosis.
Bieerkehazhi Shayahati, Aaron K McDowell-Sanchez, Patrice N Mimche, Minghua Wu, Jason J Rose
The Journal of Investigative Dermatology. 2026-08-18
Effect of nerandomilast on survival in patients with pulmonary fibrosis.
Justin M Oldham, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna-Maria Hoffmann-Vold
The European Respiratory Journal. 2026-07-30

Journal Articles

The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts
Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology

Press Mentions

Rheum to Breathe Journal ClubSeptember 24th, 2025
Durable Efficacy for Drug Preventing Lung Progression in Systemic SclerosisJuly 20th, 2022
Higher Cardiovascular Risks in Kawasaki Disease Persist 10-plus YearsNovember 8th, 2020

Grant Support

Hypoxia-Driven NUDT21-Mediated APA Promotes Lung and Skin Fibrosis in Systemic SclerosisUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2026–2031
Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic SclerosisUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2023–2028
Combined Optical Coherence Elastography and Tomography for Assessing Skin Involvement in Systemic SclerosisUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2020–2025